ALGS Q1 2026 Earnings NarrowerthanExpected Loss as Aligos Therapeutics Advances Pipeline Axsome Therapeutics Q1 2026 Earnings WiderThanExpected Loss as Pipeline Progress Takes Center Stage 111 Inc Q3 2024 Earnings Narrowed Loss per ADS Supports Positive Stock Movement Dogwood Therapeutics Inc DWTX Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Focuses on Pipeline Progress KRUS Q1 2026 Earnings NarrowerThanExpected Loss Boosts Sentiment Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline APAM Q1 2026 Earnings EPS Miss Highlights Margin Pressure Despite Steady AUM Growth VLGEA Q1 2025 Earnings Profitability Holds Steady Amidst Challenging Retail Environment Brandywine Realty Trust Q1 2026 Earnings Narrow FFO Miss as Office Market Pressure Persists NE Q1 2026 Earnings EPS Beats Estimates by 301 Stock Declines DUOT Q1 2026 Earnings Significant EPS Miss Despite Positive Stock Reaction Revelation Biosciences Inc REVB Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Continues Development Spire Inc SR Q1 2026 Earnings Beat EPS Estimates with Positive Surprise